Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Schizophrenia

Free Subscription Articles published in Pharmacopsychiatry Retrieve available abstracts of 32 articles: HTML format Text format

Single Articles

March 2010
1. SCHOEMAKER J , Naber D, Vrijland P, Panagides J, et al
   Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder.
   Pharmacopsychiatry. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. HOYER C , Kranaster L, Leweke FM, Klosterkotter J, et al
   Familial Differential Treatment Response in Schizophrenia - Lessons From a Case of Three Affected Siblings.
   Pharmacopsychiatry. 2010.
   PubMed     Text format     Related articles   
   
   
   
3. SCHMAUSS M , Diekamp B, Gerwe M, Schreiner A, et al
   Does Oral Antipsychotic Pre-Treatment Influence Outcome of a Switch to Long-Acting Injectable Risperidone in Patients with Schizophrenia?
   Pharmacopsychiatry. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. MITTRACH M , Thunker J, Winterer G, Agelink MW, et al
   The Tolerability of rTMS Treatment in Schizophrenia with Respect to Cognitive Function.
   Pharmacopsychiatry. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. ENGLISCH S , Esser A, Zink M
   Bupropion for depression in schizophrenia: a case report.
   Pharmacopsychiatry. 2010;43:38-9.
   PubMed     Text format     Related articles   
   
   
   November 2009
6. LAMBERT M , Schimmelmann BG, Naber D, Eich FX, et al
   Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride.
   Pharmacopsychiatry. 2009;42:277-283.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
7. WOBROCK T , Schneider-Axmann T, Retz W, Rosler M, et al
   Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
   Pharmacopsychiatry. 2009;42:194-201.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
8. BACHMANN CJ , Lehr D, Theisen FM, Preiss M, et al
   Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.
   Pharmacopsychiatry. 2009;42:153-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. NEUHAUS AH , Opgen-Rhein C, Urbanek C, Hahn E, et al
   COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
   Pharmacopsychiatry. 2009;42:141-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SUAREZ D , Haro JM, Novick D, Perrin E, et al
    Reasons and outcomes of olanzapine dose adjustments in the outpatient treatment of schizophrenia.
    Pharmacopsychiatry. 2009;42:135-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ZHANG Y , Lehmann M, Shobeiry A, Hofer D, et al
    Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.
    Pharmacopsychiatry. 2009;42:129-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. ENGLISCH S , Weinbrenner A, Inta D, Zink M, et al
    Aripiprazole for the management of olanzapine-induced weight gain.
    Pharmacopsychiatry. 2009;42:166-7.
    PubMed     Text format     Related articles   
    
    
    May 2009
13. SCHONFELDT-LECUONA C , Wolf RC, Osterfeld ND, Vasic N, et al
    Pregabalin in the treatment of schizophrenic anxiety.
    Pharmacopsychiatry. 2009;42:124-5.
    PubMed     Text format     Related articles   
    
    
    
14. RYCKMANS V , Kahn JP, Modell S, Werner C, et al
    Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study.
    Pharmacopsychiatry. 2009;42:114-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BERGMANN F , Zacher A, Nass A, Urban R, et al
    Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.
    Pharmacopsychiatry. 2009;42:101-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
16. WEINBRENNER S , Assion HJ, Stargardt T, Busse R, et al
    Drug prescription patterns in schizophrenia outpatients: analysis of data from a german health insurance fund.
    Pharmacopsychiatry. 2009;42:66-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
17. BAPTISTA T , Rangel N, El Fakih Y, Uzcategui E, et al
    Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial.
    Pharmacopsychiatry. 2009;42:14-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. TSCHONER A , Engl J, Rettenbacher M, Edlinger M, et al
    Effects of six second generation antipsychotics on body weight and metabolism - risk assessment and results from a prospective study.
    Pharmacopsychiatry. 2009;42:29-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
19. JAGER M , Messer T, Laux G, Pfeiffer H, et al
    Standardized Remission Criteria in Schizophrenia: Descriptive Validity and Comparability with Previously Used Outcome Measures.
    Pharmacopsychiatry. 2008;41:190-195.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LAMBERT M , Huber CG, Naber D, Schacht A, et al
    Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
    Pharmacopsychiatry. 2008;41:182-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. QI Z , Miller GW, Voit EO
    A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia.
    Pharmacopsychiatry. 2008;41 Suppl 1:S89-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MOBASCHER A , Winterer G
    The molecular and cellular neurobiology of nicotine abuse in schizophrenia.
    Pharmacopsychiatry. 2008;41 Suppl 1:S51-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. MEISENZAHL EM , Schmitt G, Grunder G, Dresel S, et al
    Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Pharmacopsychiatry. 2008;41:169-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. VERNALEKEN I , Cumming P, Grunder G
    Imaging studies - differential action of typical and atypical antipsychotics in a network perspective.
    Pharmacopsychiatry. 2008;41 Suppl 1:S60-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. GIEGLING I , Hartmann AM, Genius J, Benninghoff J, et al
    Systems biology and complex neurobehavioral traits.
    Pharmacopsychiatry. 2008;41 Suppl 1:S32-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
26. SHELDRICK AJ , Grunder G
    Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis.
    Pharmacopsychiatry. 2008;41:160.
    PubMed     Text format     Related articles   
    
    
    
27. MOLINA JD , Sole S, Pablo S, Lopez-Munoz F, et al
    Rapid onset psychosis after reduction of the risperidone dose.
    Pharmacopsychiatry. 2008;41:160-3.
    PubMed     Text format     Related articles   
    
    
    
28. MULLER UJ , Fellgiebel A
    Successful Treatment of Long-lasting Psychosis in a Case of 22q11.2 Deletion Syndrome.
    Pharmacopsychiatry. 2008;41:158-9.
    PubMed     Text format     Related articles   
    
    
    
29. FENDT M , Lex A, Falkai P, Henn FA, et al
    Behavioural alterations in rats following neonatal hypoxia and effects of clozapine: implications for schizophrenia.
    Pharmacopsychiatry. 2008;41:138-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HAAN L , Nimwegen L, Amelsvoort T, Dingemans P, et al
    Improvement of Subjective Well-being and Enduring Symptomatic Remission, A 5-Year Follow-up of First Episode Schizophrenia.
    Pharmacopsychiatry. 2008;41:125-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
31. BOSMANS A , Verbanck P
    Successful treatment of delusional disorder of the somatic type or "delusional parasitosis" with olanzapine.
    Pharmacopsychiatry. 2008;41:121-2.
    PubMed     Text format     Related articles   
    
    
    
32. BADER W , Greiner C, Haen E
    Increase of risperidone concentration under chlorprothixene comedication--a case report.
    Pharmacopsychiatry. 2008;41:116-7.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: